• Study of drug interactions between leriglitazone, gemfibrozil, itraconazole, and carbamazepine and food effects in healthy male volunteers for adrenoleukodystrophy treatment

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland

  • Study of Monthly Atacicept Injections in Patients with IgA Nephropathy (Berger Disease)

    Not recruiting

    2 1 1
    Investigated Drugs:
    Poland Spain

  • Study of cisplatin, gemcitabine and rilvegostomig treatment in patients with high-risk resectable intrahepatic cholangiocarcinoma

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study of N-803 combined with BCG treatment for patients with early-stage bladder cancer that has not invaded the muscle wall

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Germany

  • Study of ALXN2420 with somatostatin analogs for adults with acromegaly to evaluate effectiveness in lowering IGF-1 levels

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark Hungary Italy Lithuania The Netherlands Poland +1

  • Study of S095035 and TNG462 in adults with advanced or metastatic solid tumors with MTAP deletion

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark France Germany Italy Spain

  • Study comparing subcutaneous versus intravenous ublituximab in patients with relapsing multiple sclerosis

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Croatia Czechia Hungary

  • Comparing bemnifosbuvir-ruzasvir and sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in adult patients

    Not recruiting

    3 1 1
    Investigated Drugs:
    France Germany Greece Poland Romania Spain

  • Study of Zelenectide Pevedotin in Adults with Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer with NECTIN4 Amplification

    Not recruiting

    2 1 1
    Investigated Drugs:
    France Germany Italy Spain

  • Study of VS-01 with different treatment times compared to standard care alone in patients with overt hepatic encephalopathy and liver cirrhosis complications

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Spain

powered by